Evolution of delayed resistance to immunotherapy in a melanoma responder

David Liu(University of Louisville), Genevieve M. Boland(Harvard University), Jackson H. Stocking(Harvard University), Daniel P. Cahill(Harvard University), Shaolin Mei(Harvard University), Priscilla K. Brastianos(Massachusetts General Hospital), Keith T. Flaherty(Cancer Research Center), Tatyana Sharova(Harvard University), Gyulnara G. Kasumova(The Ohio State University Wexner Medical Center), Mai P. Hoang(Harvard University), Adam Kraya(Translational Therapeutics (United States)), Meenhard Herlyn(The Wistar Institute), Alvin Shi(Broad Institute), Shu Wang(Harvard University), Mohsen Malehmir(University Hospital of Zurich), Eliezer M. Van Allen(Dana-Farber Cancer Institute), Emily Robitschek(Broad Institute), Dennie T. Frederick(Broad Institute), Donald P. Lawrence(Massachusetts General Hospital), Tommy Kim(Massachusetts General Hospital), Benjamin Izar(Columbia University Irving Medical Center), Jia‐Ren Lin(Harvard University), Alex Heyde(Harvard University), Peter K. Sorger(Harvard University Press), Eytan Ruppin(Cedars-Sinai Medical Center), Kevin Bi(Broad Institute), Katherine L. Nathanson(Translational Therapeutics (United States)), Gao Zhang(Central South University), Riley Fadden(Massachusetts General Hospital), Denis Schapiro(Heidelberg University), Yu‐An Chen(Harvard University), Martin A. Nowak(Harvard University), Christine G. Lian(Brigham and Women's Hospital), Avinash Sahu(New Mexico Department of Health), Manolis Kellis(Broad Institute), Tabea Moll(Johns Hopkins University), Benchun Miao(Massachusetts General Hospital), Ryan J. Sullivan(Dana-Farber Cancer Institute), Li-Lun Ho(Broad Institute), Christopher Alvarez‐Breckenridge(Harvard University)
Nature Medicine
May 3, 2021
Cited by 135


Related Papers